Trial Profile
Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-Thalassemia
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Deferitrin (Primary) ; Deferoxamine
- Indications Iron overload
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Genzyme Corporation
- 28 May 2014 New trial record